The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market was valued at $127,107.12 thousand in 2020, and is estimated to reach $229,987.00 thousand by 2030, growing at a CAGR of 6.1% from 2021 to 2030.
Animal vaccines play a significant role in the protection of animal and public health, ensuring efficacy in the productivity of food animal sufficing the feed of ever-increasing human population. Animal vaccines have also reduced the risks posed by heavy dosage of antibiotics to food and companion animal. Veterinary vaccinations not only benefit animal health, but also have a major effect on the public health by aiding in elimination of zoonotic diseases, which transmit from animal to humans.
The growth of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market is majorly driven by alarming increase in the prevalence of animal disease, such as Foot and Mouth Disease (FMD), Black Quarter (BQ), Newcastle disease, Infectious Bursal Disease, and Fowl Pox; rise in government initiative for development of various programs to vaccinate animals; surge in number of pet and poultry population; rise in expenditure on animal healthcare; and rise in adoption of animals. For instance, according to the World Organization of Animal Health (OIE), in 2018, it was reported that around 234,848 number of poultry animal are affected with Infectious Bursal Disease, in Nepal. Moreover, in June 2020, the National Centers for Disease control, in India, announced the National action plan in order to eliminate rabies from India, through “One Health” approach. Rise in number of animal vaccination camps and surge in demand for animal vaccine drive the growth of the market. For instance, in July 2019, Indian Immunological Limited (IIL), one of the leading biological companies, organize free animal vaccination camps across 170 centers in India. As per the same source, in July 2019, approximately 50,000 dose of anti-rabies vaccine (RAKSHARAB), manufactured by IIL, was administered in as many as 20 states through NGOs, and veterinary dispensaries. Thus, increase in the number of vaccine production and rise in prevalence of rabies are expected to propel the growth of the market.
Increase in the focus on animal safety and surge in demand for innovative pet care & medication are the major factors that drive the India, Bangladesh, Sri Lanka, Nepal animal vaccine market. Moreover, increase in demand for meat, egg and milk consumption significantly contributes toward the market growth. Rise in demand for veterinary care therapy for prevention of animal from infectious disease acts as a key driving force for the expansion of the animal vaccine market. Furthermore, rise in funds by government and private organizations to develop animal vaccination camps, and free vaccination programs are expected to boost the market growth. In addition, advancements in vaccine product, and surge in demand for pet insurance in emerging nations are anticipated to provide lucrative opportunities for the market expansion. For instance, in August 2020, the Bajaj Allianz General, one of the insurance policy company in India, announced the premium for pet dog insurance policy, which initiate from $3.15 million per annum.
However, high cost of milk, egg and meat prices, due to increase in cost of animal vaccine, and adverse effect of vaccines on animal and human health are anticipated to hinder the market growth. On the contrary, rise in disposable income, increase in animal healthcare spending, and increase in awareness among the population for management of animal vaccine schedule augment the growth of the India, Bangladesh, Sri Lanka, Nepal animal vaccine sector. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities in the India, Bangladesh, Sri Lanka, Nepal animal vaccine market.
The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market is segmented on the basis of type, animal type, valence, and country. By therapy, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, and DNA Vaccines. On the basis of animal type, it is categorized into companion animal, and poultry.
Depending on valence, it is bifurcated into monovalent, and multivalent. Country wise, it is analyzed across India, Bangladesh, Sri Lanka, and Nepal.
Some of the major companies that operate in the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market are AniCon Labor Gmbh, Boehringer Ingelheim International GmbH, Cargill Animal Nutrition, Ceva Sante Animale, Hygieia Biological Laboratories, Intas Pharmaceutical Ltd., Merck KGAA, Romvac Company S.A, Sanofi, SavaVet, Vaxxinova Gmbh, Virbac S.A, Vivaldis, and Zoetis.
Animal vaccines play a significant role in the protection of animal and public health, ensuring efficacy in the productivity of food animal sufficing the feed of ever-increasing human population. Animal vaccines have also reduced the risks posed by heavy dosage of antibiotics to food and companion animal. Veterinary vaccinations not only benefit animal health, but also have a major effect on the public health by aiding in elimination of zoonotic diseases, which transmit from animal to humans.
The growth of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market is majorly driven by alarming increase in the prevalence of animal disease, such as Foot and Mouth Disease (FMD), Black Quarter (BQ), Newcastle disease, Infectious Bursal Disease, and Fowl Pox; rise in government initiative for development of various programs to vaccinate animals; surge in number of pet and poultry population; rise in expenditure on animal healthcare; and rise in adoption of animals. For instance, according to the World Organization of Animal Health (OIE), in 2018, it was reported that around 234,848 number of poultry animal are affected with Infectious Bursal Disease, in Nepal. Moreover, in June 2020, the National Centers for Disease control, in India, announced the National action plan in order to eliminate rabies from India, through “One Health” approach. Rise in number of animal vaccination camps and surge in demand for animal vaccine drive the growth of the market. For instance, in July 2019, Indian Immunological Limited (IIL), one of the leading biological companies, organize free animal vaccination camps across 170 centers in India. As per the same source, in July 2019, approximately 50,000 dose of anti-rabies vaccine (RAKSHARAB), manufactured by IIL, was administered in as many as 20 states through NGOs, and veterinary dispensaries. Thus, increase in the number of vaccine production and rise in prevalence of rabies are expected to propel the growth of the market.
Increase in the focus on animal safety and surge in demand for innovative pet care & medication are the major factors that drive the India, Bangladesh, Sri Lanka, Nepal animal vaccine market. Moreover, increase in demand for meat, egg and milk consumption significantly contributes toward the market growth. Rise in demand for veterinary care therapy for prevention of animal from infectious disease acts as a key driving force for the expansion of the animal vaccine market. Furthermore, rise in funds by government and private organizations to develop animal vaccination camps, and free vaccination programs are expected to boost the market growth. In addition, advancements in vaccine product, and surge in demand for pet insurance in emerging nations are anticipated to provide lucrative opportunities for the market expansion. For instance, in August 2020, the Bajaj Allianz General, one of the insurance policy company in India, announced the premium for pet dog insurance policy, which initiate from $3.15 million per annum.
However, high cost of milk, egg and meat prices, due to increase in cost of animal vaccine, and adverse effect of vaccines on animal and human health are anticipated to hinder the market growth. On the contrary, rise in disposable income, increase in animal healthcare spending, and increase in awareness among the population for management of animal vaccine schedule augment the growth of the India, Bangladesh, Sri Lanka, Nepal animal vaccine sector. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities in the India, Bangladesh, Sri Lanka, Nepal animal vaccine market.
The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market is segmented on the basis of type, animal type, valence, and country. By therapy, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, and DNA Vaccines. On the basis of animal type, it is categorized into companion animal, and poultry.
Depending on valence, it is bifurcated into monovalent, and multivalent. Country wise, it is analyzed across India, Bangladesh, Sri Lanka, and Nepal.
Some of the major companies that operate in the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market are AniCon Labor Gmbh, Boehringer Ingelheim International GmbH, Cargill Animal Nutrition, Ceva Sante Animale, Hygieia Biological Laboratories, Intas Pharmaceutical Ltd., Merck KGAA, Romvac Company S.A, Sanofi, SavaVet, Vaxxinova Gmbh, Virbac S.A, Vivaldis, and Zoetis.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market.
KEY MARKET SEGMENTS
By Type
- Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- DNA Vaccines
By Animal Type
- Companion Animal
- Dogs
- Cats
- Poultry
By Valence
- Monovalent
- Multivalent
By Country
- India
- Bangladesh
- Sri Lanka
- Nepal
KEY MARKET PLAYERS
- AniCon Labor Gmbh
- Boehringer Ingelheim International GmbH
- Cargill Animal Nutrition
- Ceva Sante Animale
- Hygieia Biological Laboratories
- Intas Pharmaceutical Ltd.
- Merck KGAA
- Romvac Company S.A
- Sanofi
- SavaVet
- Vaxxinova Gmbh
- Virbac S.A
- Vivaldis
- Zoetis
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY TYPE
CHAPTER 5: INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY ANIMAL TYPE
CHAPTER 6: INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY VALENCE
CHAPTER 7: INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY COUNTRY
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Anicon Labor Gmbh
- Boehringer Ingelheim International Gmbh
- Cargill Animal Nutrition
- Ceva Sante Animale
- Hygieia Biological Laboratories
- Intas Pharmaceutical Ltd
- Merck Kgaa
- Romvac Company S.A
- Sanofi
- Savavet
- Vaxxinova Gmbh
- Virbac S.A
- Vivaldis
- Zoetis
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 152 |
| Published | December 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 127107.12 thousand |
| Forecasted Market Value ( USD | $ 229987 thousand |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Bangladesh, India, Nepal, Sri Lanka |
| No. of Companies Mentioned | 14 |
